Pfizer Call for Grant Application - Advances in the Treatment of Renal Cell Carcinoma

20 Apr 2017 11:29 AM | NAMEC Staff Jim Ranieri (Administrator)

Pfizer
Independent Grants for Learning & Change

Call for Grant Applications (CGA)
Advances in the Treatment of Renal Cell Carcinoma
 
Date CGA Issued: April 19, 2017
Clinical Area: Renal Cell Carcinoma
Geographic Scope: United States, Europe
Link to full CGA: Advances in the Treatment of Renal Cell Carcinoma
Due Date: May 31, 2017
 
Specific Area of Interest:  It is our intent to support continuing professional development programs (CME/CE) for medical oncologists, urologists, nurses, nurse practitioners, physician assistants and other healthcare professionals involved in the care and treatment of patients with RCC. Proposed programs should focus on understanding adjuvant therapy in oncology. Other topics of interest are current and future treatment sequencing with tyrosine-kinase inhibitors (TKIs) and adverse event management for patients with RCC.
 
Questions regarding this CGA should be directed to derek.warnick@pfizer.com.


Find a medical education company 

NAMEC
3416 Primm Lane
Birmingham, AL 35216
(205) 824-7612
 

Staffed by Prime Management Services, an Association Management Company

© 2016 NAMEC. All rights reserved.

Powered by Wild Apricot Membership Software